Piroxicam Premedication for Postendodontic Pain in Non-vital Mandibular Molars
Status:
Unknown status
Trial end date:
2020-12-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to evaluate the effect of piroxicam (20mg) compared to placebo on
post-endodontic pain of single-visit endodontic treatment of non-vital mandibular molars.